期刊文献+

一种改良的纤维平板法 被引量:3

An Improved Fiber Plate Method
在线阅读 下载PDF
导出
摘要 介绍一种改良的用以快速地定性和半定量检测纤溶活性蛋白的纤维平板法.对该方法中的几个关键因素作了详细的研究和探讨.纤维平板中纤维蛋白原和纤溶酶原的浓度对裂解面积不产生任何影响,但是纤维蛋白原的浓度会对裂解圈的观察产生影响,纤维蛋白原浓度低于0.2 mg/mL时会使背景色过淡而不能清晰地观察到裂解圈.尿激酶浓度在2~250 mU/μL范围时,尿激酶浓度的对数和裂解圈相互垂直的两条直径乘积的对数之间存在明显的线性关系.在本实验设计方案下,尿激酶的最佳使用浓度为10~20 mU/μL.同时,本文还探讨了纤维平板中纤溶酶原的去活条件,当琼脂纤维平板凝固后很难完全去活纤溶酶原,但是,在琼脂纤维蛋白原混合物凝固前于95℃持续温浴40 min,则能彻底去活纤维蛋白原中残留的纤溶酶原. It establishes an improved fiber plate method, which can be used for qualitative and semiquantitative analysis. Several key factors were studied and discussed. The concentration of fibrinogen and plasminogen contained in the fibrin plate did not have any effect on the fibrinolytic area. However, the concentration of fibrinogen had influence on the observation and image gathering of fibrinolytic zones. It was difficult to clearly observe the fibrinolytic zones when the concentration of fibrinogen was below 02 mg/mL. The logarithm of the product of the two perpendicular diameters was linearly related to the logarithm of the concentration of urokinase when the concentration of urokinase was among 2~250 mU/μL. In the experiment, the optical concentration of urokinase was among 10~20 mU/μL. It is found that it is hard to denature plasmin by heating the agarfibrin plate after the agar is solidified. However, the plasmin is completely denatured when heated at 95 ℃ for 40 minutes before the agar is solidified.
出处 《广东工业大学学报》 CAS 2012年第3期87-91,共5页 Journal of Guangdong University of Technology
基金 海口市重点科技计划项目(2011-0044)
关键词 纤维平板法 纤维蛋白原 纤溶酶原 尿激酶 fibrin plate method fibrinogen plasminogen urokinase
  • 相关文献

参考文献1

二级参考文献4

  • 1郑铃,包幼迪.改良溶解圈纤溶酶原激活物测定法及其在革兰氏阴性菌中的应用[J].中国人兽共患病杂志,1996,12(4):7-10. 被引量:5
  • 2Petter F, Marta K, Stig G, et al. Methods for determination of plasmin,antiplasmin and plasminogen by means of substrate s-2251 [ J ].Haemostasis , 1978,7:138.
  • 3Astrup T, Astrup T, Mullertz S, et al.The fibrin plate method for the estimation of fibrinolytic activity[ J]. Arch Biochem Biophs, 1952,40:346.
  • 4萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T.分子克隆实验指南[M]:第2版[M].北京:科学出版社,1999.933.

共引文献3

同被引文献26

  • 1李兴暖,韩雅莉.土鳖虫纤溶活性蛋白抗小鼠血栓形成作用研究[J].中药药理与临床,2008,24(5):44-46. 被引量:8
  • 2张利,李强.一种新型的溶栓药物——纳豆激酶[J].山东农业大学学报(自然科学版),2004,35(2):307-310. 被引量:4
  • 3胡三觉,田巧莲.一种新的体内血栓形成动物模型[J].中华血液学杂志,1993,14(10):541-542. 被引量:55
  • 4崔堂兵,韩双艳,舒薇,郭勇.豆豉纤溶酶的酶动力性质研究[J].广东工业大学学报,2006,23(3):26-30. 被引量:2
  • 5Wierda D, Smith H W,Zwick C M. lmmunogenicity of biop- harmaceuticals in laboratory animals[ J ]. Toxicology,2001, 158(1/2) :71-74.
  • 6Tillmann H C, Kuhn B, Kranzlin B, et al. Efficacy and im- munogenicity of novel erythropoietic agents and conventional rhEPO in rats with renal insufficiency [ J ]. Kidney Int, 2006,69( 1 ) :60-67.
  • 7Borges M B,Kato S E, Damaso C R, et al. Accuracy and re- peatability of a micro plaque reduction neutralization test for vaccinia antibodies[ J ]. Biologicals ,2008,36 ( 2 ) : 105-110.
  • 8Shankar G, Shores E, Wagner C, et al. Scientific and regu- latory considerations on the immunogenicity of biologics [ J ]. Trends Biotechnol, 2006,24 ( 6 ) : 274-280.
  • 9Wadhwa M,Thorpe R. Unwanted immunogenicity: lessons learned and future challenges [ J ]. Bioanalysis, 2010, 2 (6) :1073-1084.
  • 10Stas P, Lasters I. Strategies for preclinieal immunogenicity assessment of protein therapeutics [ J ]. IDrugs, 2009, 12 (3) :169-173.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部